Rep. Smith Introduces Bipartisan Bill to Pay Pharmacists for Testing and Treating Flu, COVID, and Strep
This bill is moving through the House committee process after a committee voted to approve a revised version on May 20, 2026. It must now be reported to the full House for further consideration. While most bills do not receive a committee vote, this proposal is actively moving forward.
Scores run from -100 (strongly harmful) to +100 (strongly beneficial) for each group, combining impact, certainty, scope, and duration ratings of 1-5. How impact scoring works
Independent and community pharmacy owners would gain a new revenue stream by being able to bill Medicare Part B directly for testing and treating respiratory illnesses. This is particularly significant for pharmacies in rural or underserved areas where they may be the most accessible healthcare provider, potentially helping them stay financially viable.
Ordered to be Reported in the Nature of a Substitute by Voice Vote.
The committee approved this bill and is sending it to the full chamber for a vote. This is a significant step — most bills never get this far.
Committee Consideration and Mark-up Session Held
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.
The Ensuring Community Access to Pharmacist Services (ECAPS) Act of 2025 (H.R. 3164) seeks to ensure continued access to pharmacist-administered testing and treatment for conditions such as COVID-19, flu, and RSV by establishing Medicare Part B coverage and reimbursement for these services.
The AMA and 80 physician organizations are sounding the alarm about H.R. 3164, which would let pharmacists evaluate, diagnose, and treat patients. Critics argue the bill inappropriately allows pharmacists to perform medical services without the necessary education or training.
While landmark PBM reforms were signed into law in early 2026, the American Pharmacists Association expressed disappointment that H.R. 3164 (ECAPS) was not included in the final Consolidated Appropriations Act, leaving a gap in Medicare coverage for essential pharmacist-provided clinical services.
No votes recorded for this bill yet.
Document Type
Congressional Bill
Official Title
Ensuring Community Access to Pharmacist Services Act
Analysis generated by AI. Always verify with official sources.